COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,244 Articles (22,733 medRxiv, 8,511 bioRxiv)

Most recent first Previous |  Page 1899: Articles 18981-18990  | Next

Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United States
Pater, A. A., Bosmeny, M. S., Barkau, C. L., Ovington, K. N., Chilamkurthy, R., Parasrampuria, M., Eddington, S. B., Yinusa, A. O., White, A. A., Metz, P. E., Sylvain, R. J., Hebert, M. M., Benzinger, S. W., Sinha, K. T., Gagnon, K. T.
10.1101/2021.01.11.426287 — Posted: 2021-01-13
Distinct lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza
Brownlie, D., Rodahl, I., Varnaite, R., Asgeirsson, H., Glans, H., Falck-Jones, S., Vangeti, S., Buggert, M., Ljunggren, H.-G., Michaëlsson, J., Gredmark-Russ, S., Smed-Sörensen, A., Marquardt, N.
10.1101/2021.01.13.426553 — Posted: 2021-01-13
Ineffectual AEC1 Differentiation from KRT8hi Transitional Cells without Fibrosis Associated with Fatal Acute Respiratory Failure in COVID-19 ARDS
Ting, C., Aspal, M., Vaishampayan, N., Huang, S. K., Wang, F., Farver, C., Zemans, R. L.
10.1101/2021.01.12.426404 — Posted: 2021-01-13
Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant
Nelson, G., Buzko, O., Spilman, P. R., Niazi, K., Rabizadeh, S., Soon-Shiong, P. R.
10.1101/2021.01.13.426558 — Posted: 2021-01-13 Discussion: Onsite
Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution
Vrancken, B., Dellicour, S., Smith, D. M., Chaillon, A.
10.1101/2021.01.12.426373 — Posted: 2021-01-13
A rapid phenomics workflow for the in vitro identification of antiviral drugs
Rietdijk, J., Tempere, M., Pettke, A., Georgiev, P., Lapins, M., Warpman Berglund, U., Spjuth, O., Puumalainen, M.-R., Carreras-Puigvert, J.
10.1101/2021.01.13.423947 — Posted: 2021-01-13
An insight into neurotoxic and toxicity of spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?
Charlie-Silva, I., Araujo, A., Guimaraes, A., Veras, F., Braz, H., Pontes, L., Jorge, R., Belo, M., Fernandes, B., Nobrega, R. H., Galdino, G., Condino-Neto, A., Galindo-Villegas, J., Machodo-Santelli, G., Sanches, P., Rezende, R., Cilli, E., Malafaia, G.
10.1101/2021.01.11.425914 — Posted: 2021-01-13
Impact of COVID-19 on the indigenous population of Brazil: A geo-epidemiological study
Alves, J. D., Abade, A. S., Peres, W. P., Borges, J. E., Santos, S. M., Scholze, A. R.
10.1101/2021.01.12.21249703 — Posted: 2021-01-13
Immunochromatographic SARS-CoV-2 IgG antibody assay: a cross-sectional study conducted at Wakayama Medical University in Japan
Iwabuchi, S., Katsuda, M., Koizumi, Y., Hatai, M., Kojima, M., Tokudome, N., Tamura, S., Nishio, M., Kondo, T., Hironishi, M., Kakutani, C., Yamaue, H., Hashimoto, S.
10.1101/2021.01.10.21249421 — Posted: 2021-01-13
Modelling the impact of household size distribution on the transmission dynamics of COVID-19
Liu, P., McQuarrie, L., Song, Y., Colijn, C.
10.1101/2021.01.12.21249707 — Posted: 2021-01-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).